Table 1.

Summary of target group and injury characteristics in the current study

Target Group Characteristics	Mean (SD)
Injuries, n  Female subjects  Male subjects	B-ANX n = 27 n = 12 n = 15	B-DEP n = 40 n = 13 n = 27	B-ANX&DEP n = 53 n = 19 n = 34	B-NEITHER n = 1232 n = 512 n = 720
	Total n = 1352  Female subjects, n = 556; Total % = 41.12%  Male subjects, n = 796; Total % = 58.88%
Age, y	19.40 (1.37) Median = 19  Age 17, n = 40  Age 18, n = 390  Age 19, n = 340  Age 20, n = 265  Age 21, n = 196  Age 22, n = 75  Age 23, n = 18  Age 24, n = 5
Participation in primary sport, y	10.79 (4.00) for n = 931; Range, 1-15 “NA”, n = 398
Previous concussions, n	0.72 (0.87); Range, 0-7 Median = 1 “NA”, n = 12
Current use of prescription medications	“No”, n = 935 “Yes”, n = 376  Birth control, n = 210  Antidepressants, n = 33  Anti-anxiety medication, n = 21  Sleep sedatives, n = 8  Psychostimulant, n = 22
+ Reported diagnosed anxiety	0 %
+ Reported diagnosed depression	0 %
B-ANX	0.06 (0.24)
B-DEP	0.07 (0.25)
Injury characteristics
Time until asymptomatic, days	17.38 (35.01)
Time to return-to-play, days	27.25 (37.93)
SCAT3 total symptoms 24 hours postconcussion, n	10.02 (6.32)
SCAT3 symptom severity 24 hours postconcussion, n	23.51 (21.53)
SCAT3 total symptoms 6 mo postconcussion (n)	0.70 (1.74)
SCAT3 symptom severity 6 mo postconcussion, n	1.07 (3.48)

B-ANX, elevated anxiety symptoms only on BSI-18; B-DEP, elevated depression symptoms only on BSI-18; BSI-18, Brief Symptom Inventory 18; SCAT3, Sport Concussion Assessment Tool.